Abstract
The concepts of informed consent and surveillance of human research designed to protect human subjects is commendable. The regulations of the Institutional Review Board (IRB) are having a major impact on clinical cancer research. There is greater administrative time needed of the investigator, the mechanisms of patient care have become cumbersome and some patients reject optional medical management that could be life saving. IRB regulations must be flexible to meet the needs of human subjects as well as those of the clinical investigator.
Similar content being viewed by others
References
Kennedy, B.K., Calabresi, P., Carbone, P.P., Frei, E. III, Holland, J.F., Owens, A.H., Sleisinger, M.H., & Beck, J.C. Training program in medical oncology.Am Intern Med, 78, 1973, 127–130.
Frereich, E.The Cancer Letter, 7, November 6, 1981, 5.
Kennedy, B.J. & Lillehaugen, A. Patient recall of informed consent.Med and Ped Onc, 7, 1979, 173–178.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kennedy, B.J. Impact of Institutional Review Boards on cancer research. J Med Hum 5, 27–32 (1984). https://doi.org/10.1007/BF01103644
Issue Date:
DOI: https://doi.org/10.1007/BF01103644